Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam plus haloperidol to enhance morphine effect in opium dependent patients
IRCT2016041219971N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of midazolam, haloperidol and morphine in opioid use disorder (OUD), sponsored by Tehran University of Medical Sciences. Started Sep 2011; status: completed.
02
Drugs
midazolamhaloperidolmorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on IRCT2016041219971N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016041219971N2.